Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Suramin and Tyrosine

drug:

Suramin

supplement:

Tyrosine

Research Papers that Mention the Interaction

Treatment with suramin or HGF-blocking antibodies inhibited Met tyrosine phosphorylation in all large T antigen (Tag)-positive cells and reverted the spindle-shaped morphology of spBNL.
Proceedings of the National Academy of Sciences of the United States of America  •  2001  |  View Paper
Upon testing this hypothesis in prostate cancer cell lines, we found that the most conspicuous effect of suramin was to increase the tyrosine phosphorylation of several distinct proteins.
The Journal of clinical investigation  •  1992  |  View Paper
Since suramin potently blocks tyrosine phosphorylation induced by platelet-derived growth factor but can activate the growth pathway regulated by the EGFR, biological responses of tumor cells to suramin treatment may differ dramatically.
The Journal of clinical investigation  •  1992  |  View Paper
Suramin , but not PPADS, reduced tyrosine phosphorylation in the spastic BAs.
Journal of neurosurgery  •  2002  |  View Paper
Genistein, a tyrosine kinase inhibitor, and suramin , a growth factor receptor inhibitor, both inhibited heat shock stimulation of MAPK activity and tyrosine phosphorylation of MAPK.
The Journal of Biological Chemistry  •  1997  |  View Paper
Our data show that in the presence of suramin the general level of tyrosine phosphorylation was decreased.
The Journal of Biological Chemistry  •  1995  |  View Paper
Suramin treatment resulted in a marked reduction in tyrosine phosphorylated cell surface PDGF receptors but had no effect on the level of tyrosine phosphorylation of intracellular receptor species.
Proceedings of the National Academy of Sciences of the United States of America  •  1989  |  View Paper
That suramin is a high affinity PTPase inhibitor is consistent with the observation that suramin treatment of cancer cell lines leads to an increase in tyrosine phosphorylation of several cellular proteins.
The Journal of Biological Chemistry  •  1998  |  View Paper